Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

0.5931 -0.0069 (-1.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amarin Corp ADR

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Amarin Shareholders Invited to Webcast with Board and Management Team
From Amarin Corporation plc
Via GlobeNewswire
Sarissa Capital Does Not Believe Amarin Cares About Shareholders
From Sarissa Capital Management LP
Via Business Wire
Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card “AGAINST” Sarissa’s Harmful Proposals
From Amarin Corporation plc
Via GlobeNewswire
Sarissa Capital Highlights Amarin’s Inaccurate and Misleading Statements
From Sarissa Capital Management LP
Via Business Wire
Why Amarin Stock Tumbled This Week
Amarin's tussle with its largest stakeholder doesn't appear to be sitting well with shareholders. 
Via The Motley Fool
Why Amarin Stock Was a Winner Today
The product most readily identified with the company will soon hit pharmacy shelves in Australia. 
Via The Motley Fool
BP, Hertz Global, Take-Two Interactive Software And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Amarin Mails Letter to Shareholders Highlighting Sarissa’s Myths vs. The Facts
Company Files Investor Presentation and Urges Shareholders to Vote “AGAINST” Sarissa’s Proposals on the WHITE Proxy Card 
From Amarin Corporation plc
Via GlobeNewswire
Sarissa Capital Highlights Amarin’s Disregard for Shareholder Interests and Urges Shareholders to Vote the BLUE Proxy Card for Change at Amarin
From Sarissa Capital Management LP
Via Business Wire
Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership
From Amarin Corporation plc
Via GlobeNewswire
Sarissa Capital Urges Amarin Shareholders to Vote the Blue Card by February 22 to Fix Amarin for the Benefit of Shareholders
From Sarissa Capital Management LP
Via Business Wire
Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
From Amarin Corporation plc
Via GlobeNewswire
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022 
From Amarin Corporation plc
Via GlobeNewswire
Amarin to Present at SVB Securities Global Biopharma Conference
From Amarin Corporation plc
Via GlobeNewswire
3 Penny Stocks to Sell in January Before They Peter Out
January has brought a major rally for penny stocks, but these three are likely to see their recent rallies evaporate in the coming weeks. 
Via InvestorPlace
Amarin Calls Activist Investor, Largest Shareholder Sarissa's Statement 'Inaccurate, Misleading'
Amarin Corporation Plc (NASDAQ: AMRN) reacted to its largest shareholder, Sarissa Capital Management, which said Amarin's recent board refreshment put "no shareholder representatives on the board." 
Via Benzinga
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
From Amarin Corporation plc
Via GlobeNewswire
Sarissa Capital Calls Out Amarin’s Sham Board Refreshment
From Sarissa Capital Management LP
Via Business Wire
Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders
Highlights Significant Board Refreshment, Operational and Financial Improvements and Engagement with Sarissa Capital Management 
From Amarin Corporation plc
Via GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Sarissa Capital Submits Notice to Call a Special Meeting of Amarin Shareholders to Add Directors and Remove Chairman Per Wold-Olsen
From Sarissa Capital Management LP
Via Business Wire
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
From Amarin Corporation plc
Via GlobeNewswire
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
From Amarin Corporation plc
Via GlobeNewswire
Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. 
Via Benzinga
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
Via Benzinga
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
From Amarin Corporation plc
Via GlobeNewswire
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
From Amarin Corporation plc
Via GlobeNewswire
Amarin to Present at Jefferies London Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.